Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Stage Parkinson's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03552861
What this trial is testing

Standardization and Optimization of TMS Protocols for the Treatment of PD With Depression or Cognitive Impairment

Who this might be right for
TMS Protocols in the Treatment of PD
Guangdong Provincial People's Hospital 252
Early research (Phase 1)Looking for participantsNCT07630545
What this trial is testing

A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

Who this might be right for
Parkinson's Disease (PD)Mild to Moderate Parkinson's DiseaseEarly Stage Parkinson's Disease
Mission Therapeutics 106
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07804381
What this trial is testing

Disease-modifying Efficacy of Sitagliptin Therapy in Early-stage Parkinson's Disease

Who this might be right for
Parkinson Disease
Yonsei University 160
Not applicableStudy completedNCT04340492
What this trial is testing

Education for Adapted Physical Activity in Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Lille 89
Large-scale testing (Phase 3)Study completedNCT00335166
What this trial is testing

SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease

Who this might be right for
Early Stage Parkinson Disease
Solvay Pharmaceuticals 330
Large-scale testing (Phase 3)Ended earlyNCT01028586
What this trial is testing

MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918)

Who this might be right for
Idiopathic Parkinson's Disease
Newron Pharmaceuticals SPA 507
Early research (Phase 1)Study completedNCT02459886
What this trial is testing

Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease

Who this might be right for
Parkinson's DiseaseHealthy
Biogen 66
Testing effectiveness (Phase 2)Study completedNCT01060878
What this trial is testing

Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)

Who this might be right for
Parkinson's Disease
Phytopharm 425
Not applicableLooking for participantsNCT06916507
What this trial is testing

Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)

Who this might be right for
Parkinson's Disease
AbbVie 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT04777331
What this trial is testing

Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease

Who this might be right for
Parkinsons Disease
Hoffmann-La Roche 586
Early research (Phase 1)Study completedNCT01568099
What this trial is testing

Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Affiris AG 32
Early research (Phase 1)Study completedNCT02728947
What this trial is testing

Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Luye Pharma Group Ltd. 28
Testing effectiveness (Phase 2)Study completedNCT06596005
What this trial is testing

Efficacy and Safety of TJ0113 Capsule in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine 149
Not applicableLooking for participantsNCT06993142
What this trial is testing

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

Who this might be right for
Parkinson DiseaseProdromal StageNeurodegenerative Diseases+8 more
Radboud University Medical Center 600
Testing effectiveness (Phase 2)Study completedNCT06329141
What this trial is testing

Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Glaceum 99
Testing effectiveness (Phase 2)UnknownNCT04220762
What this trial is testing

Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Medi Help Line 188
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06175767
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Mthera Pharma Co., Ltd. 120
Not applicableStudy completedNCT04692116
What this trial is testing

Parkinson's Disease (PD) Treated With Focused Ultrasound Subthalamotomy at an Early Stage

Who this might be right for
Parkinson Disease
Fundación de investigación HM 12
Large-scale testing (Phase 3)Study completedNCT00599196
What this trial is testing

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease

Who this might be right for
Early Stage Parkinson's Disease
UCB Pharma 381
Large-scale testing (Phase 3)Study completedNCT01968460
What this trial is testing

Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Pharma Two B Ltd. 149
Next Page